July 10, 2018

EndoGastric Solutions Secures $30.5 Million In New Financing

REDMOND, Wash.–(BUSINESS WIRE)–EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that it has secured $30.5 million in new financing led by existing EGS investors Advanced Technology Ventures (ATV), Canaan Partners, Canepa Healthcare, Chicago Growth Partners, CRG, Radius Ventures, Sightline Partners, and several new healthcare investors excited about EGS’ commercial advances. “EGS continues to lay the foundatio


Leave Comment


Your Name *
Your Email *
Your Website

Comment *